Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.

Tamakawa N, Saio M, Suwa T, Ohe N, Yoshimura S, Iwama T, Shinoda J, Sakai N, Takami T.

Int J Mol Med. 2004 Apr;13(4):497-503.

PMID:
15010848
2.

B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.

Ando H, Saio M, Ohe N, Tamakawa N, Yu H, Nakayama T, Yoshimura S, Kaku Y, Iwama T, Shinoda J, Sakai N, Takami T.

Int J Oncol. 2002 Apr;20(4):807-12.

PMID:
11894129
3.
4.

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.

Clin Cancer Res. 2000 Jun;6(6):2268-78.

5.
6.

Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.

Elsässer-Beile U, Rindsfüser M, Grussenmeyer T, Schultze-Seemann W, Wetterauer U.

Br J Cancer. 2000 Sep;83(5):637-41.

7.
11.

Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.

Facchetti P, Prigione I, Ghiotto F, Tasso P, Garaventa A, Pistoia V.

Cancer Immunol Immunother. 1996 Mar;42(3):170-8.

PMID:
8640845
12.
13.

Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.

Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T.

J Leukoc Biol. 2008 Sep;84(3):679-88. doi: 10.1189/jlb.1107729.

PMID:
18566103
16.

Regulation of microglia by CD4+ and CD8+ T cells: selective analysis in CD45-congenic normal and Toxoplasma gondii-infected bone marrow chimeras.

Schlüter D, Meyer T, Strack A, Reiter S, Kretschmar M, Wiestler OD, Hof H, Deckert M.

Brain Pathol. 2001 Jan;11(1):44-55.

PMID:
11145203
17.
18.

Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.

Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G, Nomoto K.

Cancer Res. 1992 Feb 15;52(4):775-81.

20.

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, Snyderman C, Johnson JT, Myers E, Herberman RB, et al.

Cancer Res. 1993 Dec 1;53(23):5654-62.

Items per page

Supplemental Content

Support Center